News & Research
Find all the latest research, news and updates on Alzheimer’s disease blood-based biomarkers. Stay up to date with the latest educational materials from the BBM Workgroup.
Featured Stories
The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field
BBM Workgroup Activities & Educational Content:
Filter by Category: Research articles | News | Press Releases | Workgroup Activities | Education
CEOi Blood-Based Biomarker Symposium at AAGP 2024
CEOi held a blood-based biomarker symposium at the American Association for Geriatric Psychiatry (AAGP) 2024 Annual Meeting, “Unleashing Diagnostic Innovation: Clinical Implementation of Blood-Based Biomarkers for Alzheimer’s Disease.”
Panel Discussion at AD/PD 2024
CEOi held a panel discussion on the sidelines of AD/PD 2024. The session was moderated by George Vradenburg, Convener of CEOi, and featured Ana Pereira, Mount Sinai; Robert Perneczky, University of Munich; and Richard Batrla, Eisai.
The Hope for Early Detection of Alzheimer’s Disease
Dr. Ali Rezai told 60 Minutes that new developments in blood testing could help doctors identify patients who are at risk for Alzheimer's disease.
Blood tests can help diagnose Alzheimer's — if they're accurate enough. Not all are
Newer blood tests can help doctors diagnose Alzheimer's disease without a brain scan or spinal tap. But some tests are more accurate than others.
Plasma p-Tau-217 Assays Work Well, But No Home Run for Diagnosis
Feel like your head is spinning? Like a little blood sample in a centrifuge, perhaps? No need to panic. It just means you are straining, like the rest of us, to keep up with the Alzheimer's disease plasma biomarker development field. New markers, new assays, new protocols seem to arrive at a dizzying pace.